- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02241733
Sustainability of Pulmonary Rehab Gains
Sustainability of Rehabilitation Gains in COPD
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Rationale: Development of dynamic hyperinflation is a primary limiting factor of exercise tolerance in chronic obstructive pulmonary disease (COPD). To lessen the development of dynamic hyperinflation, and to improve exercise tolerance in COPD patients, the investigators have developed a breathing-retraining technique to be used during pulmonary rehabilitation. This breathing-retraining technique is designed to decrease respiratory rate and prolong exhalation. The investigators demonstrated that, in the short-term, hyperinflation and exercise duration improved more with breathing-retraining plus exercise-training than with exercise-training alone. Because a crucial aspect of pulmonary rehabilitation is the maintenance its short-term benefits over the long-term, the investigators now propose to test whether short-term benefits of breathing-retraining plus exercise followed by an adherence-intervention program are sustainable over the long-term Primary Hypothesis: (H1) In COPD patients, improvements in exercise duration on a constant- load treadmill test will be greater after 12 weeks of breathing-retraining plus exercise-training followed by a 42-week adherence-intervention program (1 yr. total) than after 12 weeks of exercise-training alone followed by a 42-week adherence-intervention program (1 yr. total). Secondary Hypotheses: One year after randomization, exercise-induced dynamic hyperinflation will be less during a constant-load treadmill test (H2), 6-minute walking distance will be longer (H3), and mastery over breathing will be greater (H4) in the breathing-retraining plus exercise-training group than in the exercise-alone group. Lastly (exploratory objective), the investigators will assess the effect of the patient's physiologic, psychologic and clinical phenotype on short- term and long-term responsiveness to pulmonary rehabilitation.
Methods: The proposed study is a randomized, controlled clinical trial in which 250 patients with moderate-to-severe COPD will be enrolled. One hundred forty of these patients are expected to qualify for randomization into the breathing-retraining plus exercise-training group or the exercise-training alone group. Patients will receive 12-weeks of supervised training according to group assignment (three times weekly) followed by an adherence-intervention program (weekly phone motivational interviews, home-exercise program, and monthly laboratory booster sessions). Follow-up testing will be completed at 12 weeks, and at 6 and 12 months. Testing will include pulmonary function test, incremental-load and constant-load treadmill tests, 6-minute walk test, measurements of dyspnea, assessment of respiratory and quadriceps muscle strength and endurance and quadriceps ultrasonography. Analysis: In the principal analysis of the primary outcome measure (exercise duration; H1) the investigators will compare changes in exercise duration (constant work-rate treadmill test) from baseline to end of study using 2-sample t-test (two-tailed =.05). The primary analysis will be based on intention-to-treat principles. Multiple imputation will be used for study subjects missing the 12-month measurement. This imputation model will be based on baseline characteristics of study participants. Several secondary analyses of the primary outcome measure will be performed (H2-H4). Linear regression will be used to determine whether the observed treatment benefits persist after adjustment for baseline covariates and measures of adherence to treatment. Since several measurements will be taken on each patient, mixed-models analysis will be used to compare the changes on the constant-load treadmill test over time between the two groups.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Illinois
-
Hines, Illinois, États-Unis, 60141-5000
- Edward Hines Jr. VA Hospital, Hines, IL
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- >/= 40 yrs
- FEV1 </= 70% predicted
- FEV1/FVC <70% predicted
- RV/TLC >/=120%
- SpO2 >/= 90% at peak exercise (with or without exercise)
- inspiratory capacity decline >.15L from rest to peak exercise
Exclusion Criteria:
- respiratory infection/exacerbation within the previous 4 weeks
- exercise limiting heart disease
- primary asthma
- congestive heart failure
- exercise limiting peripheral arterial disease
- stops exercise due to arthritic pain in the knee or hips
- inability to walk on the treadmill
- pregnancy
- methadone use
- any unforeseen illness or disability that would preclude exercise testing or training
- participation in a formal exercise program within the previous 12 weeks
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation factorielle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: exercise
Patients will exercise for 12 weeks and then participate in an adherence program
|
Patients will participate in a 12-week exercise program .
They will also participate in an adherence program.
|
|
Expérimental: exercise plus breathing retraining
Patients will exercise plus breathing retraining for 12 weeks and then participate in an adherence program
|
Patients will participate in a 12-week exercise program with breathing retraining.
They will also participate in an adherence program.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Duration of Exercise Time on a Constant Work-rate Treadmill Test
Délai: 52 week test
|
Patients walk on a treadmill set at a constant workrate.
The difference in the time walked on the treadmill from baseline to study completion is the primary outcome measure.
|
52 week test
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Inspiratory Capacity
Délai: 52 week test
|
Inspiratory capacity is measured at a set time during the constant workrate treadmill test.
The difference between the inspiratory capacity measured at baseline and 52 weeks is a secondary outcome.
Inspiratory capacity measured during exercise is a measure of dynamic hyperinflation.
|
52 week test
|
|
6 Minute Walk Distance
Délai: 52 weeks
|
Six-minute walk distance will be measured at 52 weeks.
The difference in distance walked in meters between baseline and 52 weeks is the secondary outcome measure.
The 6 minute walk is conducted using the guidelines issued by the American Thoracic Society.
|
52 weeks
|
|
Mastery Over Breathing
Délai: 52 weeks
|
Mastery over breathing is measured using the Chronic Respiratory Disease Questionnaire.
Specifically the subscale 'mastery" is the investigators' secondary outcome.
The difference in scores from baseline to 52 weeks is the investigators' outcome measure.
The Chronic Respiratory Disease Questionnaire is a valid and reliable questionnaire.
1=minimum score, 7=maximum with the higher score indicating greater mastery.
A higher score indicates better health.
A change of 0.5 indicates a small change, 1.0 indicates a moderate change and greater or equal to a change of 1.5 indicates a large change.
|
52 weeks
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Eileen G. Collins, PhD RN, Edward Hines Jr. VA Hospital, Hines, IL
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- O1325-R
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .